PMID: 9193851Mar 1, 1997Paper

Cytokines and pulmonary host defenses

Current Opinion in Pulmonary Medicine
T J Standiford

Abstract

The generation of a vigorous inflammatory response is essential for rapid clearance of microbes from the alveolar space. The magnitude of the inflammatory response is tightly controlled by host-derived cytokines, which mediate lung inflammation by serving as leukocyte chemoattractants, leukocyte activating factors, or afferent signals in the induction or regulation of other effector molecules. In this chapter, the role of specific cytokines in lung innate and adaptive immunity against bacterial, mycobacterial, fungal, and parasitic pathogens is reviewed. Future directions regarding the use of specific forms of immunotherapy, including compartmentalized cytokine delivery using gene therapy, as adjuvant therapy in the treatment of pneumonia are explored.

Citations

Apr 20, 2004·Critical Care Medicine·Alexandre T RottaPaul R Knight
Mar 20, 2001·Infection and Immunity·P MancusoM Peters-Golden
Oct 30, 1998·The Journal of Laboratory and Clinical Medicine·M Peters-Golden, M Coffey
Mar 10, 2001·American Journal of Physiology. Lung Cellular and Molecular Physiology·N Isowa, M Liu
Mar 22, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Anita W RijneveldTom van Der Poll
Aug 18, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·T A MooreT J Standiford

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.